National Health Investors Raises 2025 Guidance, Increases Dividend, and Reports Strong Q2 Earnings Amidst SHOP Growth and Strategic Investments
ByAinvest
Tuesday, Aug 12, 2025 2:46 pm ET2min read
MORN--
Eric Mendelsohn, NHI's President and CEO, commented on the strong performance: "We had another great quarter which exceeded our expectations. Given the strong quarterly results and continued good visibility into the second half of the year we are again raising our full year guidance and just announced an increase to our quarterly dividend." [1]
Key financial highlights include:
- Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2025, was $0.79, compared to $0.81 in the same period last year.
- NAREIT FFO per diluted common share for the three months ended June 30, 2025, was $1.19, compared to $1.18 in the same period last year.
- Normalized FFO per diluted common share for the three months ended June 30, 2025, was $1.22, compared to $1.18 in the same period last year.
NHI's financial position remains strong, with a net debt to adjusted EBITDA ratio of 3.9x and available liquidity of $760 million as of June 30, 2025. The company's balance sheet continues to be in great shape, with over $750 million in liquidity and capital resources to continue executing on a healthy pipeline of deals.
The company's strong performance was driven by acquisitions completed in the first half of the year, excellent year-over-year SHOP growth, and continued collections on deferral repayments. NHI also transitioned seven properties to its SHOP portfolio, expecting to announce additional SHOP acquisitions before the end of the next quarter.
Despite some challenges related to specific operators and occupancy trends, the overall sentiment was optimistic, driven by robust growth and strategic investments. NHI is well-positioned for several years of excellent growth, with multiple internal and external growth opportunities, a competitive cost of capital, and a favorable macro environment.
NHI is updating its 2025 full-year guidance range to include:
- NAREIT FFO per diluted common share to a range of $4.46 - $4.50 from $4.64 - $4.70.
- Normalized FFO per diluted common share to a range of $4.78 - $4.82 from $4.68 - $4.73.
- Normalized FAD to a range of $227.9 million - $229.8 million from $223.8 million - $226.4 million.
References:
[1] https://www.morningstar.com/news/accesswire/1057350msn/nhi-announces-second-quarter-2025-results
NHI--
National Health Investors reported strong Q2 earnings with 29% YoY growth in Senior Housing Operating Portfolio NOI, increased 2025 guidance, and a dividend increase for the first time in four years. The company's financial position remains robust, with a net debt to adjusted EBITDA ratio of 3.9x and available liquidity of $760 million. Despite some challenges related to specific operators and occupancy trends, the overall sentiment was optimistic, driven by robust growth and strategic investments.
National Health Investors, Inc. (NYSE: NHI) reported robust second-quarter (Q2) 2025 earnings, with a 29% year-over-year (YoY) growth in Senior Housing Operating Portfolio (SHOP) net operating income (NOI). The company also raised its full-year 2025 guidance and announced an increase in its quarterly dividend for the first time in four years.Eric Mendelsohn, NHI's President and CEO, commented on the strong performance: "We had another great quarter which exceeded our expectations. Given the strong quarterly results and continued good visibility into the second half of the year we are again raising our full year guidance and just announced an increase to our quarterly dividend." [1]
Key financial highlights include:
- Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2025, was $0.79, compared to $0.81 in the same period last year.
- NAREIT FFO per diluted common share for the three months ended June 30, 2025, was $1.19, compared to $1.18 in the same period last year.
- Normalized FFO per diluted common share for the three months ended June 30, 2025, was $1.22, compared to $1.18 in the same period last year.
NHI's financial position remains strong, with a net debt to adjusted EBITDA ratio of 3.9x and available liquidity of $760 million as of June 30, 2025. The company's balance sheet continues to be in great shape, with over $750 million in liquidity and capital resources to continue executing on a healthy pipeline of deals.
The company's strong performance was driven by acquisitions completed in the first half of the year, excellent year-over-year SHOP growth, and continued collections on deferral repayments. NHI also transitioned seven properties to its SHOP portfolio, expecting to announce additional SHOP acquisitions before the end of the next quarter.
Despite some challenges related to specific operators and occupancy trends, the overall sentiment was optimistic, driven by robust growth and strategic investments. NHI is well-positioned for several years of excellent growth, with multiple internal and external growth opportunities, a competitive cost of capital, and a favorable macro environment.
NHI is updating its 2025 full-year guidance range to include:
- NAREIT FFO per diluted common share to a range of $4.46 - $4.50 from $4.64 - $4.70.
- Normalized FFO per diluted common share to a range of $4.78 - $4.82 from $4.68 - $4.73.
- Normalized FAD to a range of $227.9 million - $229.8 million from $223.8 million - $226.4 million.
References:
[1] https://www.morningstar.com/news/accesswire/1057350msn/nhi-announces-second-quarter-2025-results

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet